Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes
暂无分享,去创建一个
Kevin L. Boehme | Timothy J. Hohman | J. Kauwe | T. Hohman | D. Fardo | P. Nelson | Y. Katsumata | L. Shade | Merilee A. Teylan | A. Dugan | S. Mukherjee | J. Schneider | Alzheimer's Disease Genetics Consortium | J. Schneider
[1] Kevin L. Boehme,et al. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study , 2021, Acta neuropathologica communications.
[2] Yongjun Cao,et al. A Role of the Podoplanin-CLEC-2 Axis in Promoting Inflammatory Response After Ischemic Stroke in Mice , 2020, Neurotoxicity Research.
[3] Samantha J. Ma,et al. Brain arteriolosclerosis , 2020, Acta Neuropathologica.
[4] K. Lunetta,et al. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. , 2020, JAMA neurology.
[5] Pavel P. Kuksa,et al. Large meta-analysis of genome-wide association studies expands knowledge of the genetic etiology of Alzheimer disease and highlights potential translational opportunities , 2020, medRxiv.
[6] Kevin L. Boehme,et al. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy , 2020, Acta Neuropathologica.
[7] F. Schmitt,et al. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. , 2020, JAMA neurology.
[8] D. Bennett,et al. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease , 2020, Neurobiology of Aging.
[9] Q. Gao,et al. C‐type lectin‐like receptor 2 and zonulin are associated with mild cognitive impairment and Alzheimer's disease , 2020 .
[10] E. Bacchelli,et al. An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray , 2020, Scientific Reports.
[11] Timothy J. Hohman,et al. Genetic variants and functional pathways associated with resilience to Alzheimer’s disease , 2020, bioRxiv.
[12] E. Vassos,et al. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease , 2019, Translational Psychiatry.
[13] Gerta Rücker,et al. How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.
[14] Alzheimer's Disease Neuroimaging Initiative,et al. Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases , 2019, bioRxiv.
[15] M. Nowakowska,et al. The WWOX Gene Influences Cellular Pathways in the Neuronal Differentiation of Human Neural Progenitor Cells , 2019, Front. Cell. Neurosci..
[16] Timothy J. Hohman,et al. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease , 2019, Molecular Psychiatry.
[17] C. Jack,et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.
[18] J. Lambert,et al. The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? , 2019, Acta Neuropathologica.
[19] Genetic,et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.
[20] D. Fardo,et al. Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy , 2019, Laboratory Investigation.
[21] Timothy J. Hohman,et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.
[22] Christopher D. Brown,et al. INFERNO: inferring the molecular mechanisms of noncoding genetic variants , 2018, Nucleic acids research.
[23] J. Belleroche,et al. Amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes , 2018, Cell Stress and Chaperones.
[24] Joel S. Perlmutter,et al. Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease , 2018, Front. Neurosci..
[25] Andries T Marees,et al. A tutorial on conducting genome‐wide association studies: Quality control and statistical analysis , 2018, International journal of methods in psychiatric research.
[26] K. Lunetta,et al. Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease , 2018, Alzheimer's Research & Therapy.
[27] Rebecca C. Knickmeyer,et al. Genome-wide association analysis identifies common variants influencing infant brain volumes , 2017, Translational Psychiatry.
[28] Dan Jackson,et al. Power analysis for random‐effects meta‐analysis , 2017, Research synthesis methods.
[29] L. Hegedüs,et al. Common genetic variants associated with thyroid function may be risk alleles for Hashimoto's disease and Graves' disease , 2016, Clinical endocrinology.
[30] Mitchell J. Machiela,et al. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..
[31] C. Sze,et al. WW domain-containing oxidoreductase in neuronal injury and neurological diseases , 2014, OncoTarget.
[32] G. Kovacs,et al. Prevalence of mixed pathologies in the aging brain , 2014, Alzheimer’s Research & Therapy.
[33] Paul T. von Hippel,et al. Estimates of heterogeneity (I2) can be biased in small meta-analyses , 2014, 1410.2296.
[34] A. Singleton,et al. Genetic variability in the regulation of gene expression in ten regions of the human brain , 2014, Nature Neuroscience.
[35] M. Farrer,et al. Genetics and genomics of Parkinson’s disease , 2014, Genome Medicine.
[36] Charles D. Smith,et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology , 2014, Acta Neuropathologica.
[37] M. Pirinen,et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.
[38] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[39] Jeffrey A Lieberman,et al. Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia , 2011, Neuropsychopharmacology.
[40] E. Porcellini,et al. Alzheimer's disease gene signature says: beware of brain viral infections , 2010, Immunity & Ageing.
[41] Eden R Martin,et al. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms , 2008, Genetic epidemiology.
[42] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[43] J. Heath,et al. Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro , 2004, Journal of Biological Chemistry.
[44] D. Gavaghan,et al. An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data , 2000, Pain.
[45] Charles D. Smith,et al. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. , 2014, Brain : a journal of neurology.
[46] Y. Kuo,et al. Role of WWOX/WOX1 in Alzheimer's disease pathology and in cell death signaling. , 2012, Frontiers in bioscience.
[47] Tanya M. Teslovich,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..